Retinopathy

Elana Gotkine WEDNESDAY, May 31, 2023 (HealthDay News) -- For patients with diabetes, an automated binary diabetic macular ischemia (DMI) algorithm using optical coherence tomography…

Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal…

<!-- Name:DistributionId Value:8839139 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:2790 -->…

<!-- Name:DistributionId Value:8832991 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

MONDAY, March 20, 2023 (HealthDay News) -- The prevalence of diabetic retinopathy (DR) is 6.99 percent in pediatric type 2 diabetes (T2D) and increases with time since diagnosis, according to a meta-analysis published online March 17 in…

<!-- Name:DistributionId Value:8789598 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:2790 -->…

<!-- Name:DistributionId Value:8745775 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…

<!-- Name:DistributionId Value:8739912 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:9500 -->…

Oral APX3330 Achieved Statistical Significance on a Key Pre-specified Secondary Endpoint of Preventing Clinically Meaningful Progression of Diabetic Retinopathy (DR) after 24 Weeks of Treatment Oral APX3330 Demonstrated Favorable…

About one third of patients with diabetes mellitus (DM) develop diabetic retinopathy (DR), a leading cause of blindness in working-age individuals. DR typically develops after many years of DM, and some patients do not develop DR for more…